Legend Biotech to Host Investor Conference Call on Third-Quarter Results

Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN) will host a conference call on November 20, 2023, to review third-quarter results and provide an overview of its performance for the quarter.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, will host a conference call for investors at 8:00am Eastern Time on Monday, November 20, 2023, to review third-quarter results. Company executives will provide an overview of Legend Biotech’s performance for the quarter.

Investors and other interested parties may join the live audio webcast of the call via this weblink.

A replay of the webcast and the earnings news release will be available at Legend Biotech’s website at https://investors.legendbiotech.com/events-and-presentations approximately two hours after the call concludes.

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at https://legendbiotech.com/ and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231107409077/en/

Press:

Tina Carter, Corporate Communications Lead, Legend Biotech

tina.carter@legendbiotech.com

(908) 331-5025

Investors:

Jessie Yeung, Head of Investor Relations and Public Relations, Legend Biotech

jessie.yeung@legendbiotech.com

Source: Legend Biotech Corporation

FAQ

What is the date of Legend Biotech's conference call to review third-quarter results?

The conference call will be held on Monday, November 20, 2023.

Where can investors join the live audio webcast of the call?

Investors can join the live audio webcast via the weblink provided by Legend Biotech.

When will the replay of the webcast and the earnings news release be available?

The replay will be available at Legend Biotech’s website approximately two hours after the call concludes.